Cargando…
SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know so Far?
INTRODUCTION: The coronavirus pandemic has caused massive damage to global health care and the economy. The vaccination program has been paced around the globe to return as soon as possible to pre-COVID time. Although all the vaccines have been approved after the rigorous clinical and safety trials,...
Autores principales: | Shaikh, Taha Gul, Waseem, Summaiyya, Ahmed, Syed Hassan, Qadir, Nashwa Abdul, Piccolo, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681186/ https://www.ncbi.nlm.nih.gov/pubmed/36534559 http://dx.doi.org/10.5826/dpc.1204a170 |
Ejemplares similares
-
Vaccine-induced thrombotic thrombocytopenia following coronavirus vaccine: A narrative review
por: Ahmed, Syed Hassan, et al.
Publicado: (2021) -
Amyloidogenesis: What Do We Know So Far?
por: Alraawi, Zeina, et al.
Publicado: (2022) -
Neuroproteomics in Epilepsy: What Do We Know so Far?
por: do Canto, Amanda M., et al.
Publicado: (2021) -
Eosinophilic Esophagitis—What Do We Know So Far?
por: Wąsik, Jakub, et al.
Publicado: (2023) -
HIV and neoplasms: What do we know so far?
por: de Souza, Thais Faria, et al.
Publicado: (2023)